Login to Your Account



Financial review

Stock market turbulence brings queasy feeling for biopharma equities

By Peter Winter
Editor

Monday, February 12, 2018

The Dow plummeted a whopping 1,175 points last Monday, the largest single points drop on record, which played havoc with all sector equities. Although recovering back about half of the loss the following trading day, nervous investors were preparing for the worse - an extended turbulent period on the capital markets leading to a full correction of a significant 10 percent to 20 percent drop in the leading stock market indices.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription